⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4002780 | 0.74 | — | — | |
| SCHEMBL6250253 | 0.68 | — | — | |
| SCHEMBL82443 | 0.67 | — | — | |
| SCHEMBL1498208 | 0.64 | — | — | |
| SCHEMBL7222391 | 0.64 | — | — | |
| SCHEMBL216603 | 0.64 | — | — | |
| SCHEMBL2671687 | 0.64 | — | — | |
| SCHEMBL13731715 | 0.62 | — | — | |
| SCHEMBL1556331 | 0.60 | — | — | |
| Propane SCHEMBL9230394 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5071961-A | Adsorption on alpha-hydroxyaminopropyl-modified adsorber, then elution | BIOTEST PHARMA GMBH (DE) | 1991-12-10 | — | — | US | claimed |
| US-5061789-A | METHOD OF ISOLATING BLOOD-CLOTTING FACTOR IX | BIOTEST PHARMA GMBH (DE) | 1991-10-29 | — | — | US | claimed |
| EP-4365252-A2 | BLOCK POLYISOCYANATE COMPOSITION, RESIN COMPOSITION, RESIN FILM, AND LAYERED BODY | Asahi Kasei Kabushiki Kaisha (JP) | 2024-05-08 | — | — | EP | disclosed |
| EP-4364944-A1 | BLOCK POLYISOCYANATE COMPOSITION, RESIN COMPOSITION, RESIN FILM, AND LAYERED BODY | Asahi Kasei Kabushiki Kaisha (JP) | 2024-05-08 | — | — | EP | disclosed |
| EP-3771720-B1 | BLOCKED POLYISOCYANATE COMPOSITION, RESIN COMPOSITION, RESIN FILM AND LAMINATE | ASAHI CHEMICAL IND (JP) | 2024-05-01 | — | — | EP | disclosed |
| CN-116082936-B | Blocked polyisocyanate composition and method for producing same, resin composition, resin film and method for producing same, and laminate | 旭化成株式会社 | 2024-04-05 | — | — | CN | disclosed |
| EP-3689936-B1 | BLOCKED POLYISOCYANATE COMPOSITION AND USE THEREOF | ASAHI CHEMICAL IND (JP) | 2024-03-06 | — | — | EP | disclosed |
| EP-4332137-A1 | BASE COATING COMPOSITION, MULTILAYER COATING FILM LAMINATE, AND METHOD FOR FORMING MULTILAYER COATING FILM LAMINATE | Asahi Kasei Kabushiki Kaisha (JP) | 2024-03-06 | — | — | EP | disclosed |
| CN-117645828-A | Coating composition for substrate, multilayer coating film laminate, and method for forming multilayer coating film laminate | 旭化成株式会社 | 2024-03-05 | — | — | CN | disclosed |
| CN-117580887-A | Blocked polyisocyanate composition, resin film, and laminate | 旭化成株式会社 | 2024-02-20 | — | — | CN | disclosed |
| EP-4321585-A2 | BLOCKED POLYISOCYANATE COMPOSITION AND METHOD FOR PRODUCING THE SAME, RESIN COMPOSITION, RESIN FILM AND METHOD FOR PRODUCING THE SAME, AND LAMINATE | Asahi Kasei Kabushiki Kaisha (JP) | 2024-02-14 | — | — | EP | disclosed |
| CN-111183167-A | Blocked polyisocyanate composition and use thereof | 旭化成株式会社 | 2020-05-19 | — | — | CN | disclosed |
| US-6469003-B1 | COMPOUNDS HAVING CELL ADHESION INHIBITING ACTIVITY | NIHON NOHYAKU CO., LTD. (JP) | 2002-10-22 | — | — | US | disclosed |
| EP-1130015-A1 | PYRIDAZINONE DERIVATIVES | Nihon Nohyaku Co., Ltd. (JP) | 2001-09-05 | — | — | EP | disclosed |
| EP-0354354-B1 | Process for concentrating blood coagulation factors II, VII, IX en X | KRAUS MICHAEL (DE) | 1994-04-27 | — | — | EP | disclosed |
| EP-0396022-B1 | PROCESS FOR THE ISOLATION OF BLOOD COAGULATION FACTOR IX | BIOTEST PHARMA GMBH (DE) | 1992-06-03 | — | — | EP | disclosed |
| US-5071961-A | Adsorption on alpha-hydroxyaminopropyl-modified adsorber, then elution | BIOTEST PHARMA GMBH (DE) | 1991-12-10 | — | — | US | disclosed |
| US-5061789-A | METHOD OF ISOLATING BLOOD-CLOTTING FACTOR IX | BIOTEST PHARMA GMBH (DE) | 1991-10-29 | — | — | US | disclosed |
| EP-0396022-A1 | Process for the isolation of blood coagulation factor IX | BIOTEST PHARMA GMBH (DE) | 1990-11-07 | — | — | EP | disclosed |
| EP-0354354-A2 | Process for concentrating blood coagulation factors II, VII, IX en X | Kraus, Michael, Dipl.-Biol. (DE) | 1990-02-14 | — | — | EP | disclosed |